APPLICATION
ANDA075562
TYPE
ANDA
ORIGINAL APPROVAL
2001-09-27
LATEST ACTION
2007-03-29
ROUTE
RESPIRATORY (INHALATION), INHALATION
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription
Products
IPRATROPIUM BROMIDEPrescription
IPRATROPIUM BROMIDE 0.02% · SOLUTION · INHALATION
Approval history
2007-03-29Labeling · Supplement 1AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.